Remepy

3 stories about Remepy
אור שובל אמיר עמדי ו מיכל צור רמפי

Remepy raises $10 million Seed round to bring first hybrid drug to market

01.05.24|Meir Orbach
The Israeli startup’s new hybrid drugs combine traditional drugs with its “digital molecules.” Digital molecules are therapeutic interventions that trigger physiological effects through the brain